Taken together, the present data indicate that PL exhibits adequate drug-likeness properties; by inhibiting the activation of NF-κB, PL features anti-amyloidogenesis and anti-inflammatory properties that may render it an effective method to treat and/or prevent the development of AD. This evidence concerns the gene NFKB1 and Alzheimer disease.